Estrogen receptor alpha (ESR1) (ERα)

Estrogen receptor alpha is a ligand-activated nuclear receptor and transcription factor that also localizes to the plasma membrane where a palmitoylated subpopulation (including the ER46 isoform) mediates rapid, non-genomic signaling through caveolae-associated complexes (e.g., coupling to G proteins and PI3K/Akt/eNOS), promoting nitric oxide production and modulating oxidative stress in endothelium; genetic models that disrupt membrane ERα (e.g., C451A preventing palmitoylation) demonstrate its role in vascular functions such as flow-mediated dilation, sometimes in a ligand-independent manner, while the canonical nuclear ERα governs estrogen-responsive gene transcription via EREs and is a central therapeutic target in ER-positive breast cancer.

Other names

Estrogen receptor 1Nuclear receptor subfamily 3 group A member 1ER66 (full-length 66 kDa)ER46 (membrane-enriched splice/translation variant)ESR1Estrogen receptor alpha, membrane-associated (descriptive)

SERMs act as tissue-selective ERα agonists/antagonists by inducing distinct receptor conformations that alter co-regulator recruitment; antagonism in breast, agonism in bone. SERDs bind ERα LBD, antagonize transcription, and promote receptor degradation. Estrogens bind ERα to activate genomic transcription and membrane-initiated signaling cascades (e.g., PI3K/Akt/eNOS). Ligand-independent activation via phosphorylation (e.g., Ser118 by MAPK or CDK7) sustains ERα activity despite antiestrogens, impacting resistance biology.